基本信息
浏览量:0
职业迁徙
个人简介
Dr. Greenwald is considered central to the creation and growth of the field of cancer prevention, having developed a research framework that progresses from discovery to intervention to application in the real-world population. In the early 1980s, scientific debates lingered as to whether cancer control research was feasible. As such, “prevention” research then studied causality, etiology, and epidemiology, with nothing that involved intervening. His time in the New York Public Health Department as director of cancer control from 1968 to 1978 and at the Epidemic Intelligence Service at the Centers for Disease Control helped develop his view that while research on causality and mechanisms was important, to be “prevention” there needed to be intervention—action both to lower the occurrence of cancer and to bring down cancer risk.
Dr. Greenwald led the creation of the NCI community oncology program to engage local non-academic physicians, and the implementation of the first major clinical trials of agents (tamoxifen and finasteride) to prevent breast and prostate cancer. The Prostate, Colorectal, Lung, and Ovarian Cancer Screening Trial (PLCO) was carried out under his direction, and data and samples from this cohort are used in research to this day. NCI prevention research priorities then, as now, also include biomarkers, early detection, nutrition, and symptom management.
研究兴趣
论文共 69 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
MOLECULAR BASIS OF NUTRITION AND AGINGpp.567-582, (2016)
Cancer Epidemiology, Biomarkers & Preventionno. 6 (2009): 1672-1673
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn